Company Filing History:
Years Active: 2015
Title: **Elfrida R. Benjamin: Innovator in Calcium Channel Blockers**
Introduction
Elfrida R. Benjamin is an accomplished inventor based in Englishtown, New Jersey, known for her contributions to pharmacology and medicinal chemistry. With a focus on addressing pain through innovative compounds, her work has significant implications for the treatment of disorders responsive to calcium channel blockade.
Latest Patents
Elfrida holds a patent for "4-phenylsulfonamidopiperidines as calcium channel blockers." This invention pertains to a class of piperidinyl compounds that includes pharmaceutically acceptable salts, prodrugs, or solvates. The patent outlines an assay designed for identifying compounds that serve as N-type calcium channel modulators or blockers. The compounds developed under this patent are particularly noted for their potential to treat and ameliorate pain, demonstrating their importance in the pharmaceutical landscape.
Career Highlights
Currently, Elfrida R. Benjamin is associated with Purdue Pharma L.P., where her research focuses on the development of novel therapeutic agents. Her groundbreaking work contributes to advancing medical treatment options, particularly in the realm of pain management.
Collaborations
In her endeavors, Elfrida works alongside fellow researchers Zhengming Chen and Deyou Sha. Their collaborative efforts enhance the scope and efficacy of their research, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Elfrida R. Benjamin has made remarkable strides in the field of drug development, particularly in the creation of calcium channel blockers. Through her patented innovations and collaborative spirit, she continues to impact the medical field positively, offering new hope for pain management solutions.